DNA X Inc
SONM
9 hedge funds and large institutions have $384K invested in DNA X Inc in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
44% more capital invested
Capital invested by funds: $266K → $384K (+$118K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
13% more funds holding
Funds holding: 8 → 9 (+1)
1.82% less ownership
Funds ownership: 8.22% → 6.4% (-1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$130K |
| 2 |
CWM
C2C Wealth Management
Scottsdale,
Arizona
|
+$94.4K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Potomac Capital Management
New York
|
-$151K |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$42.9K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$13 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$3 |
SONM Hedge Fund Activity: Q1 2026 in Review
9 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q1 2026, worth a combined $384K — up 44% from $266K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new SONM positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $130K. The largest seller was Potomac Capital Management, exiting entirely with an estimated $151K sold.
- 9 institutional investors held DNA X Inc (SONM) as of Q1 2026, up from 8 in Q4 2025.
- Funds reported $384K of DNA X Inc stock for Q1 2026, up 44% quarter-over-quarter.
- 5 funds opened new DNA X Inc positions in Q1 2026 and 4 closed out, a net change of +1 holder.
- The largest DNA X Inc buyer in Q1 2026 was UBS Group, an estimated $130K added.
- The largest DNA X Inc seller in Q1 2026 was Potomac Capital Management, an estimated $151K sold.
Based on aggregated 13F filings for Q1 2026.